Early posthatch protection against marek's disease in chickens vaccinated in ovo with a CVI988 serotype I vaccine

Avian Diseases

Volumn 45, Issue 3, 2001, Pages 639-645

  Zhang, Y ^a   Sharma, J M ^a  

^a 258 Veterinary Science Building ^*  (United States)

Author keywords

CVI988; Early protection; In ovo vaccination; Marek's disease

Indexed keywords

EID: 0034816450     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.2307/1592905     Document Type: Article

References (26)

1. Evaluation of a modified live virus vaccine administration in ovo to protect chickens against Newcastle disease
2. Marek's disease - A model for herpesvirus oncology
3. Pathogenesis of Marek's disease virus-induced local lesions. 1. Lesion characterization and cell line establishment
4. Marek's disease
5. Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically cells and latently infected lymphoblastoid tumour cells
6. Recombinant fowlpox viruses coexpressing chickens type 1 IFN and Newcastle disease virus HN and F genes: Influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses
7. Monoclonal antibodies with specificity for 3 different serotypes of Marek's disease viruses in chickens
8. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents
9. RNA transcripts of Marek's disease virus (MDV) serotype-1 in infected and transformed cells
10. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's disease in specific-pathogen-free chickens
11. Control of Marek's disease in The Netherlands. Isolation of an avirulent Marek's disease virus (strain CVI988) and its use in laboratory vaccination trials
12. T-cell transformation by Marek's disease virus
13. Response of embryonic chicken lymphocytes to in ovo exposure to lymphotropic viruses
14. Field safety and efficacy of in ovo administration of HVT+ SB-1 bivalent Marek's disease vaccine in commercial broilers
15. Partial transcription map of Marek's disease herpesvirus in lyrically infected cells and lymphoblastoid cell lines
16. Embryo vaccination with infectious bursal disease virus alone or in combination with Marek's disease vaccine
17. Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development
18. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with turkey herpesvirus
19. Comparative viral, immunologic, and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch
20. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administrated singly or in combination
21. Characterization of Marek's disease virus-infected lymphocytes: Discrimination between cytolytically and latently infected cells
22. Latent transcripts of Marek's disease virus are clustered in the short and long repeat regions
23. Characteristics of some selected Marek's disease virus field isolaters
24. Characterisdcs of CVI988/Rispens and R2/23, two prototype vaccine strains serotype 1 Marek's disease virus
25. Isolation from turkeys of a cell associated herpesvirus antigenically related to Marek's disease virus